Postoperative Biliary Fistula Prevention After Hepatectomy
1 other identifier
interventional
304
1 country
12
Brief Summary
Aim : Effect of external biliary duct stent after hepatectomy on the occurence of postoperative biliary fistula. Methods : French prospective multicenter randomized trial. Population study: Adult patients who underwent hepatectomy (\> 2 segments) on non-cirrhotic liver. Hypothesis: decreased postoperative biliary fistula from 15% to 5% with the presence of a external biliary duct stent. With this hypothesis, the number of patients required to be equal to 152 per group for a total of 304 patients. Outcome measure: Primary : Postoperative biliary complications (biliary fistula, biloma, biliary peritonitis) Secondary : All morbidity, mortality, additional manoeuvres to treat biliary fistula, during of hospital stay and biliary fistula. Follow up: A follow-up of patients 3 months after surgery for all patients. The planned total duration of the study is 3 years and 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2009
Longer than P75 for not_applicable
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 4, 2011
CompletedFirst Posted
Study publicly available on registry
November 10, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2017
CompletedJuly 29, 2020
July 1, 2020
8.3 years
July 4, 2011
July 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative biliary fistula
3 forms of diagnosis : bile in the intra-abdominal drainage; presence of an intra-abdominal collection of bile liquid (biloma); presence of an effusion of bile in the abdominal space (biliary peritonitis).
3 months after surgey
Secondary Outcomes (2)
Morbidity
3 months after surgey
Mortality
3 months after surgery
Study Arms (2)
external biliary duct stent
EXPERIMENTAL'External Biliary duct stent in the bile duct by cystic way'
without external biliary duct stent
NO INTERVENTIONInterventions
The size of the external biliary duct stent depending of cystic duct size
Eligibility Criteria
You may qualify if:
- Subject has given his informed consent and signed consent
- Hepatectomy at least 2 segments of liver parenchyma for a benign or malignant disease by laparotomy
- Not cirrhotic liver
You may not qualify if:
- Surgery made in emergency
- Surgery by laparoscopy
- Need to draw up a bilic-digestive anastomosis
- Liver cirrhosis
- History of cholecystectomy
- Resection of less than 2 segments
- Preoperative jaundice (total bilirubin\> 30 micromol / l)
- Presence of preoperative biliary drainage
- Patients requiring the installation of a drain transcystic during the operation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (12)
CHU
Amiens, 80054, France
Hotel Dieu
Clermont-Ferrand, 63003, France
Hôpital beaujon
Clichy, 92118, France
Hôpital Claude Huriez
Lille, 59037, France
Institut Paoli Calmettes
Marseille, 13273, France
CHU la conception
Marseille, 13385, France
Hôpital St Eloi
Montpellier, 34295, France
Hotel Dieu
Nantes, 44093, France
Hôpital Saint Antoine
Paris, 75012, France
hôpital Haute Pierre
Strasbourg, 67098, France
Toulouse Purpan
Toulouse, 31000, France
Hôpital Paul Brousse
Villejuif, 94804, France
Related Publications (1)
Maulat C, Regimbeau JM, Buc E, Boleslawski E, Belghiti J, Hardwigsen J, Vibert E, Delpero JR, Tournay E, Arnaud C, Suc B, Pessaux P, Muscari F. Prevention of biliary fistula after partial hepatectomy by transcystic biliary drainage: randomized clinical trial. Br J Surg. 2020 Jun;107(7):824-831. doi: 10.1002/bjs.11405. Epub 2020 Jan 9.
PMID: 31916605RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fabrice MUSCARI, MD
University Hospital, Toulouse
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2011
First Posted
November 10, 2011
Study Start
May 1, 2009
Primary Completion
September 1, 2017
Study Completion
September 1, 2017
Last Updated
July 29, 2020
Record last verified: 2020-07
Data Sharing
- IPD Sharing
- Will not share